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Background : High microsatellite instability (MSI-H) colorectal carcinomas (CRCs) with numer-
ous mutations in the microsatellite sequence are characterized by a right-sided preponderance,
frequent peritumoral and intratumoral lymphocytic infiltration, and frequent mucin production.
However, no study has correlated anatomic site and type of genetic changes with clinicopatho-
logic changes. Methods : We analyzed the histopathologic features of 135 MSI-H CRCs and
compared them to 140 microsatellite stable (MSS) CRCs. Histopathologic changes in MSI-H
were further analyzed according to anatomic sites and genetic changes. Results : MSI-H CRCs
showed previously reported clinicopathologic findings; a right-sided preponderance, an increas-
ed number of mucinous carcinomas, and peritumoral lymphoid reactions (p<0.001 for each
variable). Increased serum CEA levels showed an MSS CRC preponderance (p=0.013). We
further analyzed the histologic differences between right- and left-sided MSI-H tumors. We
found that MSI-H CRCs on both sides had similar clinicopathologic findings, except for higher
tumor stage (p=0.048) and less frequent abnormal CEA levels in left-sided MSI-H tumors
(p=0.027). We found that not all clinicopathologic features were different between hereditary
nonpolyposis colorectal cancers (HNPCCs) and sporadic MSI-H CRCs. Conclusions :
These findings indicate that MSI-H CRCs of the left colon have similar clinicopathologic char-
acteristics as right-sided MSI-H CRCs. We did not find any significant clinicopathological dif-
ference between HNPCCs and sporadic MSI-H CRCs.
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Colorectal carcinoma (CRC) is one of the most common tumors
in Western countries and the fourth most common cancer in
both genders in Korea (Korean Statistical Informative Service,
2005). The molecular pathogenesis of CRC is well explained in
2 pathways: chromosomal instability (CIN) and microsatellite
instability (MSI).1,2 The MSI pathway begins with the inactiva-
tion of genes responsible for DNA nucleotide mismatch repair,
which results in extensive mutations in DNA sequences with
low frequencies of allelic losses and rare alterations of tumor
DNA content.3
After the discovery of MSI in cancer of the colon,4 many stud-
ies of the genetic, pathologic, and clinical features of MSI colon
cancer have been carried out. A National Cancer Institute (NCI)
workshop suggested that the form of genomic instability asso-
ciated with defective DNA mismatch repair in tumors should
be called MSI and a panel of 5 microsatellites was validated by
Ruschoff and Fishel.5 The panel was composed of 2 mononu-
cleotide repeats (bat26 and bat25) and 3 dinucleotide repeats
(D5S346, D2S123, and D7S250).6,7 Tumors were divided into
3 groups according to 5 markers: high-frequency MSI (MSI-H,
the majority of markers exhibit MSI); low-frequency MSI (MSI-
L, only a minority of markers exhibit MSI); and a group lack-
ing any apparent instability (MSS, none of the markers exhibit
MSI).5 Among these groups, MSI-H CRCs comprise 10-15%
of sporadic CRCs and most of hereditary nonpolyposis colorec-
tal cancers (HNPCCs).5
MSI-H CRCs have characteristic clinical and pathological
features compared to MSI-L and MSS CRCs such as enhanced
survival, a marked preponderance of tumors proximal to the sp-
lenic flexure, earlier tumor stage, increased diploid status, poor
differentiation, extracellular mucin production, a Crohn’s-like
lymphoid reaction, and a frequent relation to HNPCC.8-10
Until recently, although many small-scale studies had been
conducted to clarify the biologic nature of MSI-H CRCs, there
were no reports correlating histological changes according to
anatomic site and histological comparison with HNPCC-asso-
ciated MSI-H tumors versus sporadic MSI-H tumors. In order
to identify any clinicopathologic characteristics related to anatom-
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ic site and history of HNPCC, we analyzed the histopathologic
features of 135 MSI-H CRCs and grouped and analyzed them
according to anatomic site and type of genetic change.
MATERIALS AND METHODS
Case selection
A total of 135 MSI-H CRCs and 30 MSI-L CRCs from the
1,460 colon cancers that had been operated and diagnosed at Yon-
sei University Medical Center from 2003 to 2007 were includ-
ed in this study. A total of 140 MSS CRCs that had been oper-
ated and diagnosed between May and October 2005 were used
as controls. All cases had been confirmed by histological exam-
ination and molecular workup. 
MSI analysis
DNA was extracted from formalin-fixed and paraffin-embed-
ded tissue samples of 1,458 colon cancer cases. Tumor and adja-
cent normal areas were separately marked and collected for DNA
extraction. The recommended panel (bat26, bat25, D5S346,
D2S123, and D7S250) was used for genetic classification. PCR
was done and differences in amplified PCR fragments between
tumor and normal tissue were detected by gene analyzer. MSI-
H tumors were defined as having instability in 2 or more mark-
ers (Fig. 1A), MSI-L tumors as having instability in 1 marker
(Fig. 1B), and MSS tumors as showing no apparent instability
(Fig. 1C).5 MSI-H CRCs accounted for 9.68% and MSI-L
CRCs 2.05% of the 1,460 colorectal specimens that had been
accumulated over the 5 years of the study (Table 1). This study
was approved by the Institutional Review Board and informed
consent from all participants was obtained.
Analysis of clinical features
Clinical variables such as sex, mortality, anatomic site, num-
Molecular MSI-H MSI-L MSS
markers (n=135, 9.25%) (n=30, 2.05%) (n=1,295, 88.70%)
bat26 123 2 0
bat25 125 7 0
D5S346 108 5 0
D2S123 117 6 0
D7S250 121 10 0
MSI, microsatellite instability; MSI-H, high frequency MSI; MSI-L, low-
frequency MSI; MSS, microsatellite stable.
Table 1. Incidence of MSI of 5 markers according to molecular
type of CRCs
Fig. 1. Analysis of microsatellite instability in CRCs using the five
markers (bat26, bat25, D5S346, D2S123, and D7S250) and fluo-
rescence-based multiplex polymerase chain reaction show the dif-
ferences of normal (first line) and tumor (second line) tissue. (A) Two
mononucleotide repeats (bat26 and bat25) exhibit microsatellite
instability and it is interpreted as MSI-H (arrows). (B) One mononu-
cleotide repeat (bat25) exhibits microsatellite instability and this is
interpreted as MSI-L (arrow). (C) None of the markers exhibits mic-
rosatellite instability and it is interpreted as MSS. 
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ber of tumors, stage, patient survival status, HNPCC associa-
tion, and CEA level at diagnosis of CRC patients were obtained
from medical records. The anatomic site of the tumor was clas-
sified as the ascending colon, transverse colon, descending colon,
sigmoid colon, or rectum (Table 2) and divided into right and
lest-side based on the location with regard to the splenic flexure.
The number of tumor masses was determined according to
endoscopic and gross findings. For diagnosis of HNPCC, we used
the Amsterdam II criteria11,12 which were presented in 1999.
Preoperative serum CEA levels for all patients were measured at
the time of diagnosis (normal range: 0-5 ng/mL), and we divided
CRCs into 2 groups; normal (range: 0-5.0 ng/mL) and abnor-
mal (≥5.0 ng/mL).
Analysis of pathologic features
The clinicopathologic features of MSI-H and MSS CRCs were
further analyzed according to site (right vs left) and history of
HNPCC. The histological type of tumor was subclassified by
mucinous carcinoma (carcinoma containing mucin over more
than 50% of the tumor area), medullary carcinoma (poorly or
undifferentiated carcinoma containing scant tumor stroma with
intense peritumoral and intratumoral lymphocytic infiltration)
and conventional adenocarcinomas.13
Tumors were graded on the basis of glandular appearance and
divided into well differentiated (glandular structures in more than
95% of the tumor), moderately differentiated (glandular struc-
tures in 50-95% of the tumor), and poorly differentiated lesions
(glandular structures in less than 50% of the tumor). Lympho-
cytic reactions were estimated when there was more than a mod-
erate degree of peritumoral or intratumoral lymphocytic infil-
tration and/or lymphoid follicle formation.
Extracellular mucin pool formation and tumor necrosis was
rated as absent or present. The infiltrative tumor borders were
classified as irregular or pushing types. 
Statistical analysis
Statistical analysis of each parameter was performed to clarify
associations between MSI-H and MSS CRCs using the 2 test for
categorical variables and SPSS version 13.0 (SPSS Inc., Chica-
go, IL, USA). All reported p-values are 2-sided and p-values of
less than 0.05 were considered to indicate statistical signifi-
cance.
RESULTS
Different in clinicopathlogic features between MSI-H
CRCs and MSS CRCs
The clinicopathologic features of 135 MSI-H CRCs were com-
pared to 140 MSS CRCs (Table 3, 4). The significantly different
clinicopathologic features were mortality (p=0.003), anatomic
site (p<0.001), pathologic tumor stage (p<0.001), CEA level
(p=0.013), histological type and grade (p<0.001), peritumoral
and intratumoral lymphocytic reaction (p<0.001), and mucin
formation (p<0.001). However, there was no significant differ-
Variable MSI-H MSS Total
p-valuecategory No. (%) No. (%) No. (%)
Sex 0.622
Male 79 (58.5) 86 (61.4) 165 (60.0)
Female 56 (41.5) 54 (38.6) 110 (40.0)
Mortalitya 2/123 (1.6) 13/119 (10.9) 15/243 (6.2) 0.003
Stage <0.001
I 21 (15.6) 15 (10.7) 36 (13.1)
II 68 (50.4) 45 (32.1) 113 (41.1)
III 34 (25.2) 38 (27.1) 72 (26.2)
IV 12 (8.9) 42 (30.0) 54 (19.6)
Tumor site <0.001
Right 82 (60.7) 20 (14.3) 102 (37.1)
Left 53 (39.3) 120 (85.7) 173 (62.9)
Mass number 0.211
Single 128 (94.8) 137 (97.9) 265 (96.4)
Multiple 7 (5.2) 3 (2.1) 10 (3.6)
CEAb 0.013
Normal 109 (80.7) 94 (67.1) 203 (73.8)
Abnormal 26 (19.3) 46 (32.9) 72 (26.2)
History of HNPCC 8 (5.9) 0 (0.0) 8 (2.9) 0.003
a12 MSI-H CRC patients and 21 MSS CRC patients were missing in
clinical follow up; bPreoperative serum CEA level, normal (0.0-5.0
ng/mL), abnormal (higher than 5.0 ng/mL).
MSI-H, high frequency MSI; MSS, microsatellite stable; CRCs, col-
orectal carcinomas; HNPCC, hereditary nonpolyposis colorectal can-
cers.
Table 3. The comparison of clinical features between MSI-H and
MSS CRCs
Site MSI-H (%) MSS (%) Total (%)
Ascending 72 (53.3) 17 (12.1) 89 (32.4)
Transverse 10 (7.4) 1 (0.7) 11 (8.1)
Descending 15 (11.1) 9 (6.4) 24 (8.7)
Sigmoid 18 (13.3) 40 (28.6) 58 (21.1)
Rectum 20 (14.8) 73 (52.1) 93 (33.8)
Total 135 (100.0) 140 (100.0) 275 (100.0)
Table 2. Comparison of tumor location in MSI-H and MSS CRCs
MSI-H, high frequency MSI; MSS, microsatellite stable; CRCs, col-
orectal carcinomas.
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ence in sex, tumor mass number and tumor necrosis between
the 2 groups (p>0.05).
Comparison of clinicopathologic features between
right- and left-sided MSI-H CRCs
MSI-H CRCs showed a right-sided preponderance (right-sided
tumors: 82/135 [60.7%] in MSI-H CRCs vs 18/140 [12.8%]
in MSS CRCs, p<0.001). Differences between right- and left-
sided MSI-H CRCs were further analyzed (Table 5). More adv-
anced tumor stage was found in left-sided MSI-H CRCs (stage
III and IV: 20/53 [37.7%] in left-sided MSI-H CRCs vs 26/82
[31.7%] in right-sided MSI-H CRCs, p=0.022). Serum CEA
level, checked before surgery, was higher in right-than left-sided
CRCs (increased CEA level: 5/53 [9.4%] in left-sided MSI-H
CRCs vs 21/82 [24.7%] in right-sided MSI-H CRCs, p=0.027).
There was a trend toward poor survival (mortality: 2/49 [4.1%]
in left-sided MSI-H CRCs vs 0/74 [0.0%] in right-sided MSI-
H CRCs, p=0.080) and towards less mucin formation (mucin
formation: 27/53 [50.9%] in left-sided MSI-H CRCs vs 55/ 82
[67.1%] in right-sided MSI-H CRCs, p=0.061). No significant
differences in sex, survival rate, histologic type and grade of tu-
mor, peritumoral and intratumoral lymphocytic reaction, tumor
necrosis, tumor border, association with HNPCC, and 5 molec-
ular markers were found (p>0.05).
Comparison of clinicopathologic features between
HNPCCs and sporadic MSI-H CRCs
The clinicopathologic features of MSI-H CRCs were com-
pared to those of sporadic tumors and HNPCCs with HNPCC
being defined as a positive result on the Amsterdam II criteria.
We found that not all of the clinicopathologic features were dif-
ferent between CRCs from HNPCCs and sporadic MSI-H CRCs
(Table 6).
Variable Right side Left side Total
p-value
category No. (%) No. (%) No. (%)
Sex 0.996
Male 48 (58.5) 31 (58.5) 79 (58.8)
Female 34 (41.5) 22 (41.5) 56 (41.2)
Mortalitya 0/74 (0.0) 2/49 (4.1) 2/123 (1.6) 0.080
Stage 0.048
I 8 (9.8) 13 (24.5) 21 (15.4)
II 48 (58.5) 20 (37.7) 68 (50.7)
III 20 (24.4) 14 (26.4) 34 (25.0)
IV 6 (7.3) 6 (11.3) 12 (8.8)
Mass number 0.552
Single 77 (93.9) 51 (96.2) 128 (94.8)
Multiple 5 (6.1) 2 (3.8) 7 (5.2)
CEAb 0.027
Normal 61 (75.3) 48 (90.6) 109 (80.7)
Abnormal 21 (24.7) 5 (9.4) 26 (19.3)
Histological type 0.201
Medullary carcinoma 6 (7.3) 5 (9.4) 11 (8.1)
Mucinous carcinoma 27 (32.9) 10 (18.9) 41 (27.4)
Conventional carcinomas 49 (59.8) 38 (71.7) 87 (64.4)
Mucin 0.061
Absence 27 (32.9) 26 (49.1) 53 (39.3)
Presence 55 (67.1) 27 (50.9) 82 (60.7)
Histologic grade 0.386
WD 22 (26.8) 18 (34.0) 40 (29.6)
MD 16 (19.5) 13 (24.5) 29 (21.5)
PD 44 (53.7) 22 (41.5) 66 (48.9)
HNPCC 6 (7.3) 2 (3.8) 16 (11.9) 0.386
a12 MSI-H CRC patients and 21 MSS CRC patients were missing in clini-
cal follow up; bPreoperative serum CEA level: normal (0.0-5.0 ng/mL);
abnormal (higher than 5.0 ng/mL).
MSI-H, high frequency MSI; CRCs, colorectal carcinomas; WD, well
differentiated; MD, moderately differentiated; PD, poorly differentiated;
HNPCC, hereditary nonpolyposis colorectal cancers. 
Table 5. Comparison of clinicopathologic features of right- and
left-side MSI-H CRCs
Variable MSI-H MSS Total
p-value
category No. (%) No. (%) No. (%)
Histological type <0.001
Medullary carcinoma 11 (8.1) 0 (0.0) 11 (4.0)
Mucinous carcinoma 37 (27.4) 13 (9.3) 50 (18.2)
Conventional carcinomas 87 (64.4) 127 (90.7) 214 (77.8)
Mucin <0.001
Absence 53 (39.3) 98 (70.0) 151 (54.9)
Presence 82 (60.7) 42 (30.0) 124 (45.1)
Histological grade <0.001
WD 40 (29.6) 81 (57.9) 121 (44.0)
MD 29 (21.5) 41 (29.3) 70 (25.5)
PD 66 (48.9) 18 (12.9) 84 (30.5)
Peritumoral lymphocytic reaction <0.001
Absence 59 (43.7) 98 (70.0) 157 (57.1)
Presence 76 (56.3) 42 (30.0) 118 (42.9)
Intratumoral lymphocytic reaction <0.001
Absence 81 (60.0) 131 (93.6) 212 (77.1)
Presence 54 (40.0) 9 (14.3) 63 (22.9)
Necrosis 0.121
None 71 (52.6) 66 (47.1) 137 (49.8)
Focal 52 (38.5) 68 (48.6) 130 (43.6)
Extensive 12 (8.9) 6 (4.3) 18 (6.5)
Tumor border 0.002
Irregular 104 (77.0) 127 (90.7) 231 (84.0)
Pushing 31 (23.0) 13 (9.3) 44 (16.0)
MSI-H, high frequency MSI; MSS, microsatellite stable; CRCs, colorec-
tal carcinomas; WD, well differentiated; MD, moderately differentiated;
PD, poorly differentiated.
Table 4. Comparison of pathologic features of MSI-H and MSS
CRCs
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DISCUSSION
In this study, the clinicopathologic features of MSI-H CRCs
were analyzed and compared to thosed of MSS CRCs.
The incidence of MSI-H CRCs (9.25%) was slightly lower
than the previously reported incidence of 12-15% in Western
countries.5 This difference might be due to the different preferred
location of CRCs in Korean and Western populations. It is well
known that the incidence of rectal cancer in the Korean population
(58.0%) is higher than in Western populations (19.3%).14,15 A
very low incidence of MSI-H in rectal cancer has been reported,5
and this was confirmed in our study (incidence of rectal cancer:
20/135 [14.8%] in MSI-H CRCs vs 73/140 [52.1%] in MSS
CRCs, p<0.001). Therefore, the high preponderance of rectal
cancer in the Korean population would explain a slightly lower
incidence of MSI-H CRCs in our study. 5
Most of the clinicopathologic findings in our patients were
in concordance with previously reported characteristics of MSI-
H CRCs. Our MSI-H CRCs showed similarities to previously
reported clinicopathologic findings8,9: right-sided preponderance
(82/135 [60.7%] in MSI-H cancers vs 20/140 [14.3%] in MSS
cancers, p<0.001); frequent mucin formation (82/135 [60.7%]
in MSI-H cancers vs 42/140 [30.0%] in MSS cancers, p<
0.001); relatively greater number of mucinous carcinomas (37/
135 [27.4%] in MSI-H cancers vs 13/140 [9.3%] in MSS carci-
nomas, p<0.001); and more peritumoral lymphoid reactions
(76/135 [56.3%] in MSI-H cancers vs 42/140 [30.0%] in MSS
carcinoma, p<0.001). Frequent intratumoral and peritumoral
lymphoid reactions and mucin formation in MSI-H CRCs are
related to the specific subtype of CRCs; medullary and mucinous
carcinoma. We simplified the subclassification of histological
type into medullary carcinoma, mucinous carcinoma, and other
conventional adenocarcinomas,13 and used this scheme to ana-
lyze clinicopathologic features. Medullary carcinomas were pre-
sent in 11 of 135 (8.1%) MSI-H CRCs and mucinous carcino-
mas in 37 of 135 (27.4%) MSI-H CRCs. In contrast, no me-
dullary carcinoma and 13 (9%) mucinous carcinomas were pre-
sent in 140 MSS CRCs. These findings indicate that the histo-
logic type of MSI-H CRCs is different from MSS CRCs, and is
related to different biologic features.
CEA is a useful marker in screening for early disease, aiding
diagnosis, determining prognosis, predicting likely responses
to specific therapies, surveillance of patients undergoing cura-
tive resection, and monitoring the treatment of advanced dis-
ease.16,17 We found abnormal CEA level less frequently in MSI-H
CRCs than MSS CRCs (abnormal CEA level: 26/135 [19.3%]
in MSI-H CRCs vs 46/140 [32.9%] in MSS CRCs, p=0.013). In a
previous report that analyzed CEA level according to MSI-H
and MSS CRCs, Chang et al. compared clinicopathological
parameters between 19 MSI-H and 194 MSS CRCs and showed
Variable HNPCC
Sporadic 
Total
category No. (%)
CRC
No. (%)
p-value
No. (%)
Sex 0.814
Male 5 (62.5) 74 (58.3) 79 (58.5)
Female 3 (37.5) 53 (41.7) 56 (41.5)
Mortalitya 0/7 (0.0) 2/116 (1.6) 2/123 (1.7) 0.726
Stage 0.421
I 1 (12.5) 20 (15.7) 21 (15.6)
II 3 (37.5) 65 (51.2) 68 (50.4)
III 2 (25.0) 32 (25.2) 34 (25.2)
IV 2 (25.0) 10 (7.9) 12 (8.9)
Site 0.394
Right 6 (75.0) 76 (59.8) 82 (60.7)
Left 2 (25.0) 51 (40.2) 53 (39.3)
Mass number 0.495
Single 8 (100.0) 120 (94.5) 128 (94.8)
Multiple 0 (0.0) 7 (5.5) 7 (5.2)
CEAb 0.635
Normal 6 (75.0) 103 (81.7) 109 (81.3)
Abnormal 2 (25.0) 23 (18.3) 26 (18.7)
Histological type 0.602
Medullary carcinoma 0 (0.0) 11 (8.7) 11 (8.1)
Mucinous carcinoma 3 (37.5) 34 (26.8) 37 (27.4)
Conventional carcinoma 5 (62.5) 82 (64.6) 87 (64.4)
Histological grade 0.076
WD 5 (62.5) 35 (27.6) 40 (29.6)
MD 0 (0.0) 29 (22.8) 29 (21.5)
PD 3 (37.5) 63 (49.6) 66 (48.9)
Mucin 0.394
Absence 2 (25.0) 51 (40.2) 53 (39.3)
Presence 6 (75.0) 76 (59.8) 82 (60.7)
Peritumoral lymphocytic reaction 0.711
Absence 4 (50.0) 55 (43.3) 59 (43.7)
Presence 4 (50.0) 72 (56.7) 76 (56.3)
Intratumoral lymphocytic reaction 0.882
Absence 5 (62.5) 76 (59.8) 81 (60.0)
Presence 3 (37.5) 51 (40.2) 54 (40.0)
Necrosis 0.632
None 5 (62.5) 66 (52.0) 71 (52.6)
Focal 3 (37.5) 49 (38.6) 52 (38.5)
Extensive 0 (0.0) 12 (9.4) 12 (8.9)
Tumor border 0.883
Irregular 6 (75.0) 98 (77.2) 104 (77.0)
Pushing 2 (25.0) 29 (22.8) 31 (23.0)
a12 MSI-H CRC patients and 21 MSS CRC patients were missing in clini-
cal follow up; bPreoperative serum CEA level, normal (0.0-5.0 ng/mL);
abnormal (higher than 5.0 ng/mL).
HNPCC, hereditary nonpolyposis colorectal cancers; CRCs, colorectal
carcinomas; MSI-H, high frequency MSI; WD, well differentiated; MD,
moderately differentiated; PD, poorly differentiated.
Table 6. Comparison of clinicopathologic features between
HNPCCs and sporadic CRCs with MSI-H
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that MSI-H CRCs had a greater elevation in CEA level than MSS
CRCs (CEA level [>5 μg/mL]: 15/19 [78.9%] in MSI-H CRCs
vs 97/194 [50%] MSS CRCs, p=0.013).18 However, they ana-
lyzed a smaller number of MSI-H CRCs, and both MSI-H and
MSS CRCs showed higher CEA levels than our data did.
We classified tumor location as ascending colon, transverse
colon, descending colon, sigmoid colon, and rectum, and tumor
distribution was divided into right- and left-sided relative to the
splenic flexure. We validated a right-sided preponderance of
MSI-H CRCs that was statistically significant (p<0.001). We
further analyzed the difference between right- and left-sided
CRCs with MSI-H. There were no significant differences in sex,
mortality, histological type and grade, peritumoral and intratu-
moral lymphocytic reaction, necrosis, tumor border, clinical his-
tory of HNPCC, and 5 molecular markers. We found a higher
tumor stage (stage III and IV: 20/53 [37.7%] in left-sided MSI-
H CRCs vs 20/82 [31.7%] in right-sided MSI-H CRCs, p=
0.022) and a lower CEA level (increased CEA level: 5/53 [9.4%]
in left-sided MSI-H CRCs vs 21/82 [24.7%] in right-sided MSI-H
CRCs, p=0.027). These findings suggest that closer surveillance
is necessary for the detection of left-sided MSI-H CRCs.
HNPCC is a distinct autosomal dominant syndrome account-
ing for approximately 5-6% of the total colorectal cancer burden
with clinical and pathologic features caused by defective mis-
match repair genes.11 We diagnosed HNPCC cased according
to the Amsterdam II criteria and found 8 HNPCCs with MSI-
H. It is well known that the majority of HNPCCs are located
in the right colon.5 In our study, among these 8 cases, 6 (75.0%)
were located in the right colon. However, there was no statistical
significance to the difference in tumor location between MSI-H
CRCs associated with HNPCCs and sporadic MSI-H CRCs.
Decreased preoperative serum levels of CEA in HNPCC have
been reported.19 However, our study found no significant differ-
ence in serum CEA level between HNPCC and sporadic MSI-H
CRCs (p=0.635). Thus, we did not find any difference in clini-
copathological characteristics between HNPCC-related MSI-H
CRCs and sporadic MSI-H CRCs. These findings indicate that
the molecular pathways involved in the pathogenesis of MSI-H
tumors are similar although the initial inactivating mechanisms
of mismatch repair genes are different. 
CONCLUSIONS
We found that left-sided MSI-H CRCs were infrequent. How-
ever, they showed similar clinicopathological characteristics as
right-sided MSI-H CRCs, except for less frequent-mucin forma-
tion, higher tumor stage and more frequent normal CEA levels.
We could not find any significant clinicopathological differences
between HNPCC-related MSI-H CRCs and sporadic MSI-H
CRCs. These findings suggest that although the initial inacti-
vating mechanisms of mismatch repair genes were different, the
molecular pathways involved in the pathogenesis of MSI-H
tumors are homogeneous, and show similar clinicopathological
features.
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